Immunology / Atopic Dermatitis
Indication
Atopic Dermatitis
Assets addressing this indication.
Total attributable cost
$207.8B
$10,474/patient
Drug spend
$23.2B
$1,168/patient
11% of total cost is drugs
All severities, self-reported diagnosis (2024 NHIS) · US